Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Fernando Gómez-Peralta"'
Autor:
Antonio Llombart-Cussac, José Manuel Pérez-Garcia, Manuel Ruiz Borrego, Pablo Tolosa, Salvador Blanch, Adela Fernández-Ortega, Ander Urruticoechea, Isabel Blancas, Cristina Saura, Beatriz Rojas, Begoña Bermejo, José Ponce Lorenzo, María Gion, Patricia Cortez-Castedo, Elisenda Llabres, Elena Galve, Juan Fernando Cueva, Ana López, José Luis Alonso-Romero, Santiago González-Santiago, Eduardo Martínez de Dueñas, Eva Ciruelos, Griselda Martrat, Petra Gener, Daniel Alcalá-López, Miguel Sampayo-Cordero, Fernando Gómez-Peralta, Javier Cortés
Publikováno v:
EClinicalMedicine, Vol 71, Iss , Pp 102520- (2024)
Summary: Background: Hyperglycaemia is an early and frequent adverse event during alpelisib treatment. METALLICA aimed to evaluate prophylactic metformin to prevent or reduce hyperglycaemia occurrence in patients with HR+/HER2−/PIK3CA-mutated advan
Externí odkaz:
https://doaj.org/article/c5ba8bd9a6864624b463e00529accd71
Autor:
Fernando Gómez-Peralta, Xoan Valledor, Cristina Abreu, Elsa Fernández-Rubio, Laura Cotovad, Pedro Pujante, Sharona Azriel, Jesús Pérez-González, Alba Vallejo, Luis Ruiz-Valdepeñas, Rosa Corcoy
Publikováno v:
Biomedicines, Vol 12, Iss 7, p 1600 (2024)
Background: A study to assess the glucose levels of people with type 1 diabetes (T1D) overnight, based on the insulin type and timing. Methods: A real-world, retrospective study of T1D, using multiple daily insulin injections. Continuous glucose moni
Externí odkaz:
https://doaj.org/article/ff16353c65fc419596c51441b3a01039
Autor:
Desirée Ruiz, J. Antonio Fornos Pérez, Fernando Gómez-Peralta, Ana Molinero, Ignacio M. Sánchez Barrancos, Ezequiel Arranz Martínez, Inés Mera Gallego, N. Floro Andrés-Rodríguez
Publikováno v:
Farmacéuticos Comunitarios, Vol 12, Iss 4, Pp 5-20 (2020)
Introducción: la falta de adherencia implica peor control de la diabetes y aumento del número de complicaciones, lo que a menudo se traduce en un mayor gasto sanitario. Las hipoglucemias, en ocasiones inadvertidas, son una de las principales consec
Externí odkaz:
https://doaj.org/article/f033c7e86a4d4d1e80f667c93cce80ad
Autor:
Albert Lecube, Enric Sánchez, Fernando Gómez-Peralta, Cristina Abreu, Joan Valls, Olga Mestre, Odile Romero, María Dolores Martínez, Gabriel Sampol, Andreea Ciudin, Cristina Hernández, Rafael Simó
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0157579 (2016)
Type 2 diabetes (T2D) is an independent risk factor for sleep breathing disorders. However, it is unknown whether T2D affects daily somnolence and quality of sleep independently of the impairment of polysomnographic parameters.A case-control study in
Externí odkaz:
https://doaj.org/article/4ff5238605e24ca3afcd74b0f5a59c7c
Autor:
Manuel Gargallo-Fernández, Javier Escalada-San Martín, Ana Chico-Ballesteros, Edurne Lecumberri-Pascual, Cristina Tejera-Pérez, José Carlos Fernández-García, Pedro Rozas-Moreno, Amparo Marco-Martínez, Fernando Gómez-Peralta, Judith López-Fernández
Publikováno v:
Endocrinología, Diabetes y Nutrición (English ed.). 69:732-743
Publikováno v:
Endocrinología, Diabetes y Nutrición (English ed.). 68:642-653
To determine the sociodemographic and clinical profile of a representative sample of people with type 1 diabetes mellitus (DM1) in Spain and identify factors associated with glycemic control.A cross-sectional observational study was carried out in ad
Autor:
Fernando Gómez-Peralta, Cristina Abreu
Publikováno v:
Journal of clinical medicine. 11(20)
Type 2 diabetes constitutes an imposing epidemiological, economic, and scientific global challenge [...]
Autor:
Cristina Hernández, Fernando Gómez-Peralta, Olga Simó-Servat, Marta García-Ramírez, Cristina Abreu, Sara Gómez-Rodríguez, Rafael Simó
Publikováno v:
Acta diabetologica. 59(11)
The response to Glucagon-like peptide-1 receptor agonists (GLP-1RAs) is highly varia-ble among patients. Thus, the identification of predictive biomarkers of therapeutic response to GLP-1 RA could help us to optimize the use of this class of drugs. G
Autor:
Manuel Jiménez Navarro, Almudena Castro, Sara Ballesteros Pradas, Concepción Cruzado Álvarez, Juan José Gómez Doblas, Domingo Marzal Martín, Susana del Prado, Félix Valencia Serrano, Irene Bretón, Fernando Gómez Peralta, Didac Mauricio, Alfonso Soto González, Vivencio Barrios, Alberto Cordero, Juan Cosin-Sales, Xavier García-Moll, José María García Pinilla, Pilar Jiménez Quevedo, Julio Núñez Villota, Rafael Romaguera Torres, Fernando Arribas, Gemma Berga Congost, Héctor Bueno, Arturo Evangelista, Ignacio Ferreira-González, Francisco Marín, Leopoldo Pérez de Isla, Antonia Sambola, Rafael Vázquez, Ana Viana-Tejedor, Borja Ibáñez, Fernando Alfonso
Publikováno v:
Revista Española de Cardiología (English Edition). 73:354-360
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 15; Pages: 4507
Background: COVID-19 entails a higher rate of complications in subjects with type 2 diabetes mellitus (T2DM). Likewise, COVID-19 infection can cause alterations in glucose metabolism that may lead to worse control. The aim of the study was to analyse